ALKS vs EFX · P/E 14, rev $1.56B vs P/E 54, rev $5.68B
Alkermes Plc (ALKS) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the ALKS and EFX stock pages for the full models.
Not investment advice.